[ad_1] Healthscope Chairman Gordon Ballantyne said that Ellerston Capital's conditional backing to a renewed $ 4.1 billion offering from BGH Capital is not a sign that the major shareholder has lost confidence …
Read More »[ad_1] Healthscope Chairman Gordon Ballantyne said that Ellerston Capital's conditional backing to a renewed $ 4.1 billion offering from BGH Capital is not a sign that the major shareholder has lost confidence …
Read More »